+1,902.6%
HCA vs GSK
+168.4%
+1,734.3%
-54.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.6% | -1.8% | -2.7% |
| 7D | -8.1% | -4.7% | -3.3% | -6.1% |
| 30D | -1.2% | -4.7% | +3.5% | +0.9% |
| 3M | +13.3% | -8.8% | +22.1% | +17.7% |
| 6M | +14.2% | -4.6% | +18.8% | +16.4% |
| YTD | -0.9% | +1.0% | -1.9% | -2.0% |
| 1Y | -3.7% | +6.9% | -10.5% | -7.1% |
| 3Y | +91.2% | +52.5% | +38.6% | +53.2% |
| 5Y | +100.8% | +40.3% | +60.5% | +64.3% |
| 10Y | +587.7% | +99.0% | +488.8% | +371.6% |
| All | +1,902.6% | +168.4% | +1,734.3% | +1,027.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling